findmyKOL

Bridget Bagert, MD

Basic profile

Ochsner Medical Center

ORCIDNone on fileNPI
RegionNew Orleans, LA · South CentralSpecialtyNeurologyFocusNeurology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Bridget Bagert is a Neurology physician affiliated with Ochsner Medical Center. OpenAlex indexes 21 publications with 561 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex.

561citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
43companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

43 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    50.4%
    Gabapentinoids17.6%
    Gabapentin77%Pregabalin23%
    Part D45 patients
    SSRI12.5%
    Trazodone Hcl48%Escitalopram Oxalate37%Fluoxetine Hcl15%
    Part D<11 patients

    + 9 more classes in this area

  • Musculoskeletal

    23.2%
    gamma-Aminobutyric Acid-ergic Agonist16.6%
    Baclofen100%
    Part D61 patients
    Central alpha-2 Adrenergic Agonist6.6%
    Tizanidine Hcl100%
    Part D22 patients
  • Cancer & immunology

    17.9%
    Other immunostimulants5.1%
    Copaxone37%Glatopa34%Glatiramer Acetate29%
    Part D<11 patients
    CD20-directed Cytolytic Antibody4.4%
    Kesimpta Pen100%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)89.5% facility · 10.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”